SEC 13F Intelligence

Maso Capital Partners Ltd / VKTX

Maso Capital Partners Ltd’s Viking Therapeutics Inc Position

Does Maso Capital Partners Ltd own Viking Therapeutics Inc (VKTX)? Yes25.0K shares worth $657,000 (+1.08% of its 13F portfolio) as of Q3 2025, up from 15.0K shares the prior filed quarter.

Position Value
$657,000
Q3 2025
Shares
25.0K
% of Portfolio
+1.08%
Quarters Held
2
currently held

Position History VKTX

Reported value by quarter
Q2 ’25: $397,500Q2 ’25Q3 ’25: $657,000Q3 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202525.0K$657,000+1.08%
Q2 202515.0K$397,500+0.70%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Maso Capital Partners Ltd’s full portfolio or all institutional holders of VKTX.